Alethia® Group A Streptococcus
Molecular assay for the detection of Group A Streptococcus. A quick, accurate and reliable molecular assay for Group A Strep detection.
Definitive answers, confidence in results
Related Tests
Support & Documents
Downloadable PDFs
Webinars & Videos
FAQs
What are the advantages of molecular amplification for Group A Strep testing?
98% sensitivity means increased detection of positives with fewer false negatives – Eliminates subjectivity related to traditional culture methods – Rapid turn around time in comparison to 48 hours for culture, allowing for proper patient management and appropriate antibiotic treatment.
Culture is the preferred method. What are the drawbacks?
Traditional culture sensitivity is as low as 90% with optimal technique – Overgrowth of normal flora –
Variability in how the specimen is attained affecting amount of streptococci growth.
Can molecular testing be done directly from a throat swab?
Yes, a Flocked Nylon, Polyester, or Rayon swab in either Liquid Stuart or Liquid Amies, without charcoal is appropriate.
Why is Empiric Therapy to be avoided?
Unnecessary antibiotic treatment exposes patients to the expense and hazards which can lead to the development of antimicrobial resistance among common pathogens1. Up to 70% of patients receive antibiotic therapy while only 20%-30% have Group A Strep pharyngitis1. Estimated economic costs of pediatric streptococcal pharyngitis in the U.S. range from $224M to $539M per year.
What is the suggested CPT Code?
Alethia® Group A Strep – 87651
References:
1. Shulman et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis:2012 Update by the Infectious Diseases Society of America.
2. Alethia Group A Streptococcus Package Insert, SN11022.
Pricing
- Email: sales@meridianbioscience.com
- Phone: +1 800 696-0739
- International Sales Extension: +1 513 271-3000
